ft 15 dec 92 busi law patent improv robert rice explain chang ec regul affect commun pharmaceut industri look like happi new year europ pharmaceut industri januari 2 year wrangl intens lobbi european commun adopt regul grant five year extra patent protect drug extens effect period market exclus drug system supplementari protect certif spc design give pharmaceut compani fair return grow cost research develop new drug prevent research work move ec us japan drug alreadi enjoy extend patent protect legisl born polit compromis howev european spc system far straightforward procedur obtain certif complex extent differ ec state alter effect regul way implement threaten bureaucrat administr nightmar gener produc compani make patent drug licenc face period uncertainti long time widespread concern necessari safeti test new drug impos heavi penalti pharmaceut invent compar sector technolog patent europ gener last maximum 20 year applic date accord ms patricia harri intellectu properti lawyer citi solicitor lovel white durrant develop period new drug discoveri market authoris last averag 12 year complex area research diseas current regard incur alzheim motor neuron diseas multipl sclerosi develop time may even longer mean time obtain approv market drug compani littl patent term left use monopoli right recoup increasingli heavi cost research develop say although littl evid research migrat us japan patent protect longer abandon european govern accept would foolhardi wait sign declin ec pharmaceut industri take action consum organis howev warn extend patent protect could push overal drug bill public health servic across europ restrict market gener product govern recognis far push overal drug bill extend protect could use drive pharmaceut price say mr martin paltnoi pharmaceut market consult reason period market exclus guarante rational allow drug compani charg high price recoup develop cost uncertain short period patent cover longer exist work durat spc easi avail length drug develop period minu five year maximum five year develop period defin time file patent ec countri spc sought date first authoris use ec whole ms harri say mean develop period five year less supplementari protect avail develop period five 10 year spc five year avail develop period 10 20 year full five year spc appli procedur also complex separ applic made patent offic member state supplementari protect requir applic file within six month drug authoris use relev countri drug alreadi patent authoris relev member state januari 2 1993 transit provis appli applic spc must file juli 2 1993 transit provis spc product must gener first authoris use ec januari 1 1985 howev belgium itali germani denmark adopt differ date transit provis appli greec portug spain regul come forc 1998 complic matter spanish govern start proceed european court regul set asid chang mean administr headach nation patent agenc mr paltnoi believ struggl find ec drug first authoris use order calcul length spc without pool intern data accur verif first authoris may prove imposs mani case warn ms harri warn uncertain period compani produc patent drug licenc licenc usual express last durat patent spc extend patent simpli grant addit protect license want continu exclus licenc produc market drug spc renegoti licenc agreement spc go way toward meet industri requir adequ period patent protect europ say ms harri also watch interest industri agrochem also experi problem recoup r amp cost length time take obtain market authoris